Search results
Results from the WOW.Com Content Network
The journal publishes peer-reviewed scholarly articles, notes, reports, and book reviews. It is currently edited by Jos Dute, [3] Herman Nys (Editor-in-chief), [4] and Henriette Roscam Abbing. [5] It is the official journal of the European Association of Health Law. [6]
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
The European Respiratory Journal is a monthly peer-reviewed medical journal covering respirology. It was established in 1988 and is published by the European Respiratory Society, of which it is the official journal. The editor-in-chief is James D. Chalmers (University of Dundee).
The European Respiratory Review is published quarterly and focuses on state-of-the-art reviews, updates, editorials and correspondence on current topical issues in respiratory medicine, science and surgery. Its chief editor is Renata Riha. ERJ Open Research is an open access research journal, launched in 2015. [4] Its chief editor is Esther ...
This list of law journals includes notable academic periodicals on law. The law reviews are grouped by jurisdiction or country and then into subject areas. This is a dynamic list and may never be able to satisfy particular standards for completeness.
Asthma is a common pulmonary condition defined by chronic inflammation of respiratory tubes, tightening of respiratory smooth muscle, and episodes of bronchoconstriction. [1] The Centers for Disease Control and Prevention estimate that 1 in 11 children and 1 in 12 adults have asthma in the United States of America. [ 1 ]
GA²LEN, or Global Allergy and Asthma European Network, is a consortium of leading European research centres specialized in allergic diseases, including asthma. Funded by the European Union under the 6th Framework Programme, GA²LEN addresses the growing public health concern of allergic diseases. Since the launch of the Network, it has grown ...
This page was last edited on 16 November 2024, at 08:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.